1
2
3
4
Peckeu, L., van der Ende, A., de Melker, H.E., Sanders, E.A.M., Knol, M.J.
Veröffentlicht in: Vaccine ; volume 39, issue 2, page 431-437 ; ISSN 0264-410X;
2021
Veröffentlicht in: Vaccine ; volume 39, issue 2, page 431-437 ; ISSN 0264-410X;
2021
5
6
7
Schure, R.M., Hendrikx, L.H., de Rond, L.G.H., Ozturk, K., Sanders, E.A.M., Berbers, G.A.M., Buisman, A.M.
Veröffentlicht in: Schure , R M , Hendrikx , L H , de Rond , L G H , Ozturk , K , Sanders , E A M , Berbers , G A M & Buisman , A M 2012 , ' T-Cell Responses before and after the Fifth Consecutive Acellular Pertussis Vaccination in 4-Year-Old Dutch Children ' , Clinical and Vaccine Immunology , vol. 19 , no. 11 , pp. 1879-1886 . https://doi.org/10.1128/CVI.00277-12;
2012
Veröffentlicht in: Schure , R M , Hendrikx , L H , de Rond , L G H , Ozturk , K , Sanders , E A M , Berbers , G A M & Buisman , A M 2012 , ' T-Cell Responses before and after the Fifth Consecutive Acellular Pertussis Vaccination in 4-Year-Old Dutch Children ' , Clinical and Vaccine Immunology , vol. 19 , no. 11 , pp. 1879-1886 . https://doi.org/10.1128/CVI.00277-12;
2012
8
Rozenbaum, M.H., Sanders, E.A.M., van Hoek, A.J., Jansen, A.G.S.C., van der Ende, A., van den Dobbelsteen, G., Rodenburg, G.D., Hak, E., Postma, M.J.
Veröffentlicht in: Rozenbaum , M H , Sanders , E A M , van Hoek , A J , Jansen , A G S C , van der Ende , A , van den Dobbelsteen , G , Rodenburg , G D , Hak , E & Postma , M J 2010 , ' Cost effectiveness of pneumococcal vaccination among Dutch infants : an economic analysis of the seven valent pneumococcal conjugated vaccine and forecast for the 10 valent and 13 valent vaccines ' , British Medical Journal , vol. 340 , 2509 , pp. Art. No. c2509- . https://doi.org/10.1136/bmj.c2509;
2010
Veröffentlicht in: Rozenbaum , M H , Sanders , E A M , van Hoek , A J , Jansen , A G S C , van der Ende , A , van den Dobbelsteen , G , Rodenburg , G D , Hak , E & Postma , M J 2010 , ' Cost effectiveness of pneumococcal vaccination among Dutch infants : an economic analysis of the seven valent pneumococcal conjugated vaccine and forecast for the 10 valent and 13 valent vaccines ' , British Medical Journal , vol. 340 , 2509 , pp. Art. No. c2509- . https://doi.org/10.1136/bmj.c2509;
2010
9
10
van Lier, A, de Gier, B, McDonald, S.A., Mangen, M.J., Wijhe, Maarten van, Sanders, E.A.M., Kretzschmar, M.E., van Vliet, H, De Melker, H.E.
Veröffentlicht in: van Lier , A , de Gier , B , McDonald , S A , Mangen , M J , Wijhe , M V , Sanders , E A M , Kretzschmar , M E , van Vliet , H & De Melker , H E 2019 , ' Disease burden of varicella versus other vaccine-preventable diseases before introduction of vaccination into the National Immunisation Programme in the Netherlands ' , Eurosurveillance , vol. 24 , no. 18 , 1800363 . https://doi.org/10.2807/1560-7917.ES.2019.24.18.1800363;
2019
Veröffentlicht in: van Lier , A , de Gier , B , McDonald , S A , Mangen , M J , Wijhe , M V , Sanders , E A M , Kretzschmar , M E , van Vliet , H & De Melker , H E 2019 , ' Disease burden of varicella versus other vaccine-preventable diseases before introduction of vaccination into the National Immunisation Programme in the Netherlands ' , Eurosurveillance , vol. 24 , no. 18 , 1800363 . https://doi.org/10.2807/1560-7917.ES.2019.24.18.1800363;
2019